Global Molecular in Vitro Diagnostics Market Growth (Status and Outlook) 2024-2030

2024

Global Molecular in Vitro Diagnostics Market Growth (Status and Outlook) 2024-2030

Name: Global Molecular in Vitro Diagnostics Market Growth (Status and Outlook) 2024-2030
Creator: Bonafide Research
License: https://www.bonafideresearch.com/license_information

The Molecular in Vitro Diagnostics market is projected to grow from USD 23.54 Billion in 2023 to USD 36.19 Billion in 2030, driven by the increasing need for accurate and fast diag

Bonafide Trust
31-05-2024
Pages : 81
Figures : 81
Tables : 155
Region : Global
Category : Lifescience
Medical Devices

Buy Now Get Free sample

New Report Guarantee

If you purchase this report now and we update it in next 100 days, get it free!

Molecular in vitro diagnostics (IVD) involve the analysis of biological samples at the molecular and genetic levels to obtain information about an individual's health, diagnose diseases, and guide treatment decisions. These tests focus on the detection of specific nucleic acids (DNA or RNA), mutations, or other molecular markers associated with various conditions. The global Molecular in Vitro Diagnostics market size is projected to grow from US$ 23540 million in 2023 to US$ 36190 million in 2030; it is expected to grow at a CAGR of 6.3% from 2024 to 2030. Our publisher’s newest research report, the “Molecular in Vitro Diagnostics Industry Forecast” looks at past sales and reviews total world Molecular in Vitro Diagnostics sales in 2023, providing a comprehensive analysis by region and market sector of projected Molecular in Vitro Diagnostics sales for 2024 through 2030. With Molecular in Vitro Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Molecular in Vitro Diagnostics industry. This Insight Report provides a comprehensive analysis of the global Molecular in Vitro Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Molecular in Vitro Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Molecular in Vitro Diagnostics market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Molecular in Vitro Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Molecular in Vitro Diagnostics. The Molecular In Vitro Diagnostics market is driven by the increasing demand for precise and personalized diagnostic solutions in healthcare. These devices, encompassing polymerase chain reaction (PCR), nucleic acid amplification, and sequencing technologies, revolutionize disease detection by analyzing genetic material. With a focus on early and accurate diagnosis, molecular in vitro diagnostics play a pivotal role in identifying infectious diseases, genetic disorders, and cancer at a molecular level. Technological advancements, including rapid molecular assays and point-of-care testing, enhance diagnostic capabilities. The market's growth is fueled by a rising awareness of the clinical utility of molecular diagnostics, driving its integration into routine healthcare practices worldwide. Market Drivers and Challenges: Market Drivers: Increasing adoption of molecular diagnostics: Molecular diagnostics offer highly accurate and specific results by detecting and analyzing DNA, RNA, and proteins. This technology is particularly useful in the diagnosis and monitoring of infectious diseases, genetic disorders, and cancer. Growing demand for personalized medicine: The increasing awareness of personalized medicine and the need for targeted treatments are driving the demand for molecular diagnostics. Advancements in technology: Innovative technologies such as next-generation sequencing, liquid biopsy, and point-of-care (POC) testing are leading to the development of more accurate, sensitive, and efficient diagnostic tests. Increasing geriatric population: The growing geriatric population is driving the demand for molecular diagnostics, as age-related diseases such as cancer, Alzheimer’s, and Parkinson’s require accurate and early diagnosis. Rise in healthcare expenditure: The increasing healthcare expenditure and government initiatives to improve healthcare infrastructure are driving the demand for molecular diagnostics. Market Challenges: High cost of molecular diagnostics: Molecular diagnostics are often expensive, making them inaccessible to many patients, especially in developing countries. Complexity of molecular diagnostics: Molecular diagnostics require specialized expertise and equipment, which can be a barrier to adoption in some regions. Regulatory challenges: The regulatory landscape for molecular diagnostics is complex, with varying regulations across different regions, which can hinder market growth. Limited awareness: Limited awareness about the benefits of molecular diagnostics among healthcare professionals and patients can slow down adoption. Shortage of skilled professionals: The shortage of skilled professionals to operate and interpret molecular diagnostic tests is a significant challenge in many regions. Reimbursement issues: Reimbursement issues and lack of coverage for molecular diagnostics in some regions can hinder market growth. Technological Development: The global molecular in vitro diagnostics (IVD) market is witnessing significant technological advancements, driven by the increasing demand for accurate and rapid diagnostic solutions. The market is expected to grow at a compound annual growth rate (CAGR) of 4.5% from 2024 to 2030, reaching a value of USD 118.44 billion by 2030. Key Trends and Developments: Molecular Diagnostics: Molecular diagnostics is expected to be the fastest-growing segment in the IVD market, driven by the increasing adoption of molecular diagnostic tests for infectious diseases, genetic disorders, and cancer. Next-Generation Sequencing (NGS): NGS is a rapidly growing technology in the molecular diagnostics market, offering high-throughput and cost-effective sequencing capabilities. Liquid Biopsy: Liquid biopsy is a non-invasive diagnostic technique that involves analyzing circulating tumor cells or DNA in blood or other bodily fluids to detect cancer. Artificial Intelligence (AI) and Machine Learning (ML): AI and ML are being increasingly used in IVD to improve diagnostic accuracy, reduce false positives, and streamline workflows. Point-of-Care (POC) Testing: POC testing is gaining popularity, enabling healthcare professionals to perform diagnostic tests at the patient’s bedside or in remote locations. Microfluidics: Microfluidics is a technology that enables the manipulation of small volumes of fluids to perform diagnostic tests, offering improved sensitivity and specificity. Single-Molecule Real-Time (SMRT) Sequencing: SMRT sequencing is a technology that enables the detection of genetic mutations and variations at the single-molecule level, offering high accuracy and sensitivity. Recommendations and Opportunities: The global molecular in vitro diagnostics (IVD) market is expected to reach $138.4 billion by 2032, growing at a CAGR of 4.1% from 2023 to 2032. The market is driven by the increasing demand for personalized medicine, growing adoption of molecular diagnostics, and advancements in technology. Recommendations: Invest in Next-Generation Sequencing (NGS): NGS is expected to be a key driver of growth in the molecular IVD market. Companies should invest in NGS technology to stay competitive and capitalize on the growing demand for targeted therapies. Develop Point-of-Care (POC) Molecular Diagnostics: POC molecular diagnostics is a growing trend in the industry, offering the potential for faster and more convenient testing. Companies should develop POC molecular diagnostics solutions to cater to the growing demand for rapid testing. Focus on Infectious Disease Testing: Infectious disease testing is a significant segment of the molecular IVD market, driven by the growing need for accurate and timely diagnosis of infectious diseases. Companies should focus on developing molecular diagnostics solutions for infectious disease testing. Invest in Artificial Intelligence (AI) and Machine Learning (ML): AI and ML can improve the accuracy and efficiency of molecular diagnostics. Companies should invest in AI and ML to stay competitive and improve their molecular diagnostics solutions. Partner with Pharmaceutical Companies: Pharmaceutical companies are increasingly partnering with molecular diagnostics companies to develop companion diagnostics for their therapies. Companies should consider partnering with pharmaceutical companies to capitalize on this trend. Opportunities: Growing Demand for Personalized Medicine: The growing demand for personalized medicine is driving the adoption of molecular diagnostics. Companies that develop molecular diagnostics solutions for personalized medicine will have a significant opportunity to capitalize on this trend. Advancements in Technology: Advancements in technology, such as NGS and POC molecular diagnostics, are driving innovation in the molecular IVD market. Companies that invest in these technologies will have a competitive advantage. Increasing Adoption of Molecular Diagnostics: Molecular diagnostics is becoming increasingly important in healthcare, driven by the growing need for accurate and timely diagnosis. Companies that develop molecular diagnostics solutions will have a significant opportunity to capitalize on this trend. Growing Demand for Rapid Testing: The demand for rapid testing is growing, driven by the need for faster and more convenient testing. Companies that develop POC molecular diagnostics solutions will have a significant opportunity to capitalize on this trend. Growing Demand for Companion Diagnostics: The growing demand for companion diagnostics is driving the adoption of molecular diagnostics. Companies that develop companion diagnostics will have a significant opportunity to capitalize on this trend. This report presents a comprehensive overview, market shares, and growth opportunities of Molecular in Vitro Diagnostics market by product type, application, key players and key regions and countries. Segmentation by type Consumables Equipment Segmentation by application Genetic Disease Infectious Diseases Tumor Other This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. Roche Siemens Abbott Danaher Thermo Fisher BioMerieux Bio-Rad BD KHB Daan Gene Leadman Zhongsheng Bsbe Maccura Hitachi Canon Sysmex Auto Bio Mindray Bgi Wondfo

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Manmayi Raval

Research Consultant

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Molecular in Vitro Diagnostics Market Size 2019-2030
2.1.2 Molecular in Vitro Diagnostics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Molecular in Vitro Diagnostics Segment by Type
2.2.1 Consumables
2.2.2 Equipment
2.3 Molecular in Vitro Diagnostics Market Size by Type
2.3.1 Molecular in Vitro Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Molecular in Vitro Diagnostics Market Size Market Share by Type (2019-2024)
2.4 Molecular in Vitro Diagnostics Segment by Application
2.4.1 Genetic Disease
2.4.2 Infectious Diseases
2.4.3 Tumor
2.4.4 Other
2.5 Molecular in Vitro Diagnostics Market Size by Application
2.5.1 Molecular in Vitro Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Molecular in Vitro Diagnostics Market Size Market Share by Application (2019-2024)
3 Molecular in Vitro Diagnostics Market Size by Player
3.1 Molecular in Vitro Diagnostics Market Size Market Share by Players
3.1.1 Global Molecular in Vitro Diagnostics Revenue by Players (2019-2024)
3.1.2 Global Molecular in Vitro Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Molecular in Vitro Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Molecular in Vitro Diagnostics by Regions
4.1 Molecular in Vitro Diagnostics Market Size by Regions (2019-2024)
4.2 Americas Molecular in Vitro Diagnostics Market Size Growth (2019-2024)
4.3 APAC Molecular in Vitro Diagnostics Market Size Growth (2019-2024)
4.4 Europe Molecular in Vitro Diagnostics Market Size Growth (2019-2024)
4.5 Middle East & Africa Molecular in Vitro Diagnostics Market Size Growth (2019-2024)
5 Americas
5.1 Americas Molecular in Vitro Diagnostics Market Size by Country (2019-2024)
5.2 Americas Molecular in Vitro Diagnostics Market Size by Type (2019-2024)
5.3 Americas Molecular in Vitro Diagnostics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Molecular in Vitro Diagnostics Market Size by Region (2019-2024)
6.2 APAC Molecular in Vitro Diagnostics Market Size by Type (2019-2024)
6.3 APAC Molecular in Vitro Diagnostics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Molecular in Vitro Diagnostics by Country (2019-2024)
7.2 Europe Molecular in Vitro Diagnostics Market Size by Type (2019-2024)
7.3 Europe Molecular in Vitro Diagnostics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Molecular in Vitro Diagnostics by Region (2019-2024)
8.2 Middle East & Africa Molecular in Vitro Diagnostics Market Size by Type (2019-2024)
8.3 Middle East & Africa Molecular in Vitro Diagnostics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Molecular in Vitro Diagnostics Market Forecast
10.1 Global Molecular in Vitro Diagnostics Forecast by Regions (2025-2030)
10.1.1 Global Molecular in Vitro Diagnostics Forecast by Regions (2025-2030)
10.1.2 Americas Molecular in Vitro Diagnostics Forecast
10.1.3 APAC Molecular in Vitro Diagnostics Forecast
10.1.4 Europe Molecular in Vitro Diagnostics Forecast
10.1.5 Middle East & Africa Molecular in Vitro Diagnostics Forecast
10.2 Americas Molecular in Vitro Diagnostics Forecast by Country (2025-2030)
10.2.1 United States Molecular in Vitro Diagnostics Market Forecast
10.2.2 Canada Molecular in Vitro Diagnostics Market Forecast
10.2.3 Mexico Molecular in Vitro Diagnostics Market Forecast
10.2.4 Brazil Molecular in Vitro Diagnostics Market Forecast
10.3 APAC Molecular in Vitro Diagnostics Forecast by Region (2025-2030)
10.3.1 China Molecular in Vitro Diagnostics Market Forecast
10.3.2 Japan Molecular in Vitro Diagnostics Market Forecast
10.3.3 Korea Molecular in Vitro Diagnostics Market Forecast
10.3.4 Southeast Asia Molecular in Vitro Diagnostics Market Forecast
10.3.5 India Molecular in Vitro Diagnostics Market Forecast
10.3.6 Australia Molecular in Vitro Diagnostics Market Forecast
10.4 Europe Molecular in Vitro Diagnostics Forecast by Country (2025-2030)
10.4.1 Germany Molecular in Vitro Diagnostics Market Forecast
10.4.2 France Molecular in Vitro Diagnostics Market Forecast
10.4.3 UK Molecular in Vitro Diagnostics Market Forecast
10.4.4 Italy Molecular in Vitro Diagnostics Market Forecast
10.4.5 Russia Molecular in Vitro Diagnostics Market Forecast
10.5 Middle East & Africa Molecular in Vitro Diagnostics Forecast by Region (2025-2030)
10.5.1 Egypt Molecular in Vitro Diagnostics Market Forecast
10.5.2 South Africa Molecular in Vitro Diagnostics Market Forecast
10.5.3 Israel Molecular in Vitro Diagnostics Market Forecast
10.5.4 Turkey Molecular in Vitro Diagnostics Market Forecast
10.5.5 GCC Countries Molecular in Vitro Diagnostics Market Forecast
10.6 Global Molecular in Vitro Diagnostics Forecast by Type (2025-2030)
10.7 Global Molecular in Vitro Diagnostics Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Molecular in Vitro Diagnostics Product Offered
11.1.3 Roche Molecular in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Siemens
11.2.1 Siemens Company Information
11.2.2 Siemens Molecular in Vitro Diagnostics Product Offered
11.2.3 Siemens Molecular in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Siemens Main Business Overview
11.2.5 Siemens Latest Developments
11.3 Abbott
11.3.1 Abbott Company Information
11.3.2 Abbott Molecular in Vitro Diagnostics Product Offered
11.3.3 Abbott Molecular in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Abbott Main Business Overview
11.3.5 Abbott Latest Developments
11.4 Danaher
11.4.1 Danaher Company Information
11.4.2 Danaher Molecular in Vitro Diagnostics Product Offered
11.4.3 Danaher Molecular in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Danaher Main Business Overview
11.4.5 Danaher Latest Developments
11.5 Thermo Fisher
11.5.1 Thermo Fisher Company Information
11.5.2 Thermo Fisher Molecular in Vitro Diagnostics Product Offered
11.5.3 Thermo Fisher Molecular in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Thermo Fisher Main Business Overview
11.5.5 Thermo Fisher Latest Developments
11.6 BioMerieux
11.6.1 BioMerieux Company Information
11.6.2 BioMerieux Molecular in Vitro Diagnostics Product Offered
11.6.3 BioMerieux Molecular in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 BioMerieux Main Business Overview
11.6.5 BioMerieux Latest Developments
11.7 Bio-Rad
11.7.1 Bio-Rad Company Information
11.7.2 Bio-Rad Molecular in Vitro Diagnostics Product Offered
11.7.3 Bio-Rad Molecular in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Bio-Rad Main Business Overview
11.7.5 Bio-Rad Latest Developments
11.8 BD
11.8.1 BD Company Information
11.8.2 BD Molecular in Vitro Diagnostics Product Offered
11.8.3 BD Molecular in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 BD Main Business Overview
11.8.5 BD Latest Developments
11.9 KHB
11.9.1 KHB Company Information
11.9.2 KHB Molecular in Vitro Diagnostics Product Offered
11.9.3 KHB Molecular in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 KHB Main Business Overview
11.9.5 KHB Latest Developments
11.10 Daan Gene
11.10.1 Daan Gene Company Information
11.10.2 Daan Gene Molecular in Vitro Diagnostics Product Offered
11.10.3 Daan Gene Molecular in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Daan Gene Main Business Overview
11.10.5 Daan Gene Latest Developments
11.11 Leadman
11.11.1 Leadman Company Information
11.11.2 Leadman Molecular in Vitro Diagnostics Product Offered
11.11.3 Leadman Molecular in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Leadman Main Business Overview
11.11.5 Leadman Latest Developments
11.12 Zhongsheng
11.12.1 Zhongsheng Company Information
11.12.2 Zhongsheng Molecular in Vitro Diagnostics Product Offered
11.12.3 Zhongsheng Molecular in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Zhongsheng Main Business Overview
11.12.5 Zhongsheng Latest Developments
11.13 Bsbe
11.13.1 Bsbe Company Information
11.13.2 Bsbe Molecular in Vitro Diagnostics Product Offered
11.13.3 Bsbe Molecular in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Bsbe Main Business Overview
11.13.5 Bsbe Latest Developments
11.14 Maccura
11.14.1 Maccura Company Information
11.14.2 Maccura Molecular in Vitro Diagnostics Product Offered
11.14.3 Maccura Molecular in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Maccura Main Business Overview
11.14.5 Maccura Latest Developments
11.15 Hitachi
11.15.1 Hitachi Company Information
11.15.2 Hitachi Molecular in Vitro Diagnostics Product Offered
11.15.3 Hitachi Molecular in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Hitachi Main Business Overview
11.15.5 Hitachi Latest Developments
11.16 Canon
11.16.1 Canon Company Information
11.16.2 Canon Molecular in Vitro Diagnostics Product Offered
11.16.3 Canon Molecular in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Canon Main Business Overview
11.16.5 Canon Latest Developments
11.17 Sysmex
11.17.1 Sysmex Company Information
11.17.2 Sysmex Molecular in Vitro Diagnostics Product Offered
11.17.3 Sysmex Molecular in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Sysmex Main Business Overview
11.17.5 Sysmex Latest Developments
11.18 Auto Bio
11.18.1 Auto Bio Company Information
11.18.2 Auto Bio Molecular in Vitro Diagnostics Product Offered
11.18.3 Auto Bio Molecular in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Auto Bio Main Business Overview
11.18.5 Auto Bio Latest Developments
11.19 Mindray
11.19.1 Mindray Company Information
11.19.2 Mindray Molecular in Vitro Diagnostics Product Offered
11.19.3 Mindray Molecular in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Mindray Main Business Overview
11.19.5 Mindray Latest Developments
11.20 Bgi
11.20.1 Bgi Company Information
11.20.2 Bgi Molecular in Vitro Diagnostics Product Offered
11.20.3 Bgi Molecular in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Bgi Main Business Overview
11.20.5 Bgi Latest Developments
11.21 Wondfo
11.21.1 Wondfo Company Information
11.21.2 Wondfo Molecular in Vitro Diagnostics Product Offered
11.21.3 Wondfo Molecular in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 Wondfo Main Business Overview
11.21.5 Wondfo Latest Developments
12 Research Findings and Conclusion

Table 1. Molecular in Vitro Diagnostics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions) Table 2. Major Players of Consumables Table 3. Major Players of Equipment Table 4. Molecular in Vitro Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions) Table 5. Global Molecular in Vitro Diagnostics Market Size by Type (2019-2024) & ($ Millions) Table 6. Global Molecular in Vitro Diagnostics Market Size Market Share by Type (2019-2024) Table 7. Molecular in Vitro Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions) Table 8. Global Molecular in Vitro Diagnostics Market Size by Application (2019-2024) & ($ Millions) Table 9. Global Molecular in Vitro Diagnostics Market Size Market Share by Application (2019-2024) Table 10. Global Molecular in Vitro Diagnostics Revenue by Players (2019-2024) & ($ Millions) Table 11. Global Molecular in Vitro Diagnostics Revenue Market Share by Player (2019-2024) Table 12. Molecular in Vitro Diagnostics Key Players Head office and Products Offered Table 13. Molecular in Vitro Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024) Table 14. New Products and Potential Entrants Table 15. Mergers & Acquisitions, Expansion Table 16. Global Molecular in Vitro Diagnostics Market Size by Regions 2019-2024 & ($ Millions) Table 17. Global Molecular in Vitro Diagnostics Market Size Market Share by Regions (2019-2024) Table 18. Global Molecular in Vitro Diagnostics Revenue by Country/Region (2019-2024) & ($ millions) Table 19. Global Molecular in Vitro Diagnostics Revenue Market Share by Country/Region (2019-2024) Table 20. Americas Molecular in Vitro Diagnostics Market Size by Country (2019-2024) & ($ Millions) Table 21. Americas Molecular in Vitro Diagnostics Market Size Market Share by Country (2019-2024) Table 22. Americas Molecular in Vitro Diagnostics Market Size by Type (2019-2024) & ($ Millions) Table 23. Americas Molecular in Vitro Diagnostics Market Size Market Share by Type (2019-2024) Table 24. Americas Molecular in Vitro Diagnostics Market Size by Application (2019-2024) & ($ Millions) Table 25. Americas Molecular in Vitro Diagnostics Market Size Market Share by Application (2019-2024) Table 26. APAC Molecular in Vitro Diagnostics Market Size by Region (2019-2024) & ($ Millions) Table 27. APAC Molecular in Vitro Diagnostics Market Size Market Share by Region (2019-2024) Table 28. APAC Molecular in Vitro Diagnostics Market Size by Type (2019-2024) & ($ Millions) Table 29. APAC Molecular in Vitro Diagnostics Market Size Market Share by Type (2019-2024) Table 30. APAC Molecular in Vitro Diagnostics Market Size by Application (2019-2024) & ($ Millions) Table 31. APAC Molecular in Vitro Diagnostics Market Size Market Share by Application (2019-2024) Table 32. Europe Molecular in Vitro Diagnostics Market Size by Country (2019-2024) & ($ Millions) Table 33. Europe Molecular in Vitro Diagnostics Market Size Market Share by Country (2019-2024) Table 34. Europe Molecular in Vitro Diagnostics Market Size by Type (2019-2024) & ($ Millions) Table 35. Europe Molecular in Vitro Diagnostics Market Size Market Share by Type (2019-2024) Table 36. Europe Molecular in Vitro Diagnostics Market Size by Application (2019-2024) & ($ Millions) Table 37. Europe Molecular in Vitro Diagnostics Market Size Market Share by Application (2019-2024) Table 38. Middle East & Africa Molecular in Vitro Diagnostics Market Size by Region (2019-2024) & ($ Millions) Table 39. Middle East & Africa Molecular in Vitro Diagnostics Market Size Market Share by Region (2019-2024) Table 40. Middle East & Africa Molecular in Vitro Diagnostics Market Size by Type (2019-2024) & ($ Millions) Table 41. Middle East & Africa Molecular in Vitro Diagnostics Market Size Market Share by Type (2019-2024) Table 42. Middle East & Africa Molecular in Vitro Diagnostics Market Size by Application (2019-2024) & ($ Millions) Table 43. Middle East & Africa Molecular in Vitro Diagnostics Market Size Market Share by Application (2019-2024) Table 44. Key Market Drivers & Growth Opportunities of Molecular in Vitro Diagnostics Table 45. Key Market Challenges & Risks of Molecular in Vitro Diagnostics Table 46. Key Industry Trends of Molecular in Vitro Diagnostics Table 47. Global Molecular in Vitro Diagnostics Market Size Forecast by Regions (2025-2030) & ($ Millions) Table 48. Global Molecular in Vitro Diagnostics Market Size Market Share Forecast by Regions (2025-2030) Table 49. Global Molecular in Vitro Diagnostics Market Size Forecast by Type (2025-2030) & ($ Millions) Table 50. Global Molecular in Vitro Diagnostics Market Size Forecast by Application (2025-2030) & ($ Millions) Table 51. Roche Details, Company Type, Molecular in Vitro Diagnostics Area Served and Its Competitors Table 52. Roche Molecular in Vitro Diagnostics Product Offered Table 53. Roche Molecular in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 54. Roche Main Business Table 55. Roche Latest Developments Table 56. Siemens Details, Company Type, Molecular in Vitro Diagnostics Area Served and Its Competitors Table 57. Siemens Molecular in Vitro Diagnostics Product Offered Table 58. Siemens Main Business Table 59. Siemens Molecular in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 60. Siemens Latest Developments Table 61. Abbott Details, Company Type, Molecular in Vitro Diagnostics Area Served and Its Competitors Table 62. Abbott Molecular in Vitro Diagnostics Product Offered Table 63. Abbott Main Business Table 64. Abbott Molecular in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 65. Abbott Latest Developments Table 66. Danaher Details, Company Type, Molecular in Vitro Diagnostics Area Served and Its Competitors Table 67. Danaher Molecular in Vitro Diagnostics Product Offered Table 68. Danaher Main Business Table 69. Danaher Molecular in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 70. Danaher Latest Developments Table 71. Thermo Fisher Details, Company Type, Molecular in Vitro Diagnostics Area Served and Its Competitors Table 72. Thermo Fisher Molecular in Vitro Diagnostics Product Offered Table 73. Thermo Fisher Main Business Table 74. Thermo Fisher Molecular in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 75. Thermo Fisher Latest Developments Table 76. BioMerieux Details, Company Type, Molecular in Vitro Diagnostics Area Served and Its Competitors Table 77. BioMerieux Molecular in Vitro Diagnostics Product Offered Table 78. BioMerieux Main Business Table 79. BioMerieux Molecular in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 80. BioMerieux Latest Developments Table 81. Bio-Rad Details, Company Type, Molecular in Vitro Diagnostics Area Served and Its Competitors Table 82. Bio-Rad Molecular in Vitro Diagnostics Product Offered Table 83. Bio-Rad Main Business Table 84. Bio-Rad Molecular in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 85. Bio-Rad Latest Developments Table 86. BD Details, Company Type, Molecular in Vitro Diagnostics Area Served and Its Competitors Table 87. BD Molecular in Vitro Diagnostics Product Offered Table 88. BD Main Business Table 89. BD Molecular in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 90. BD Latest Developments Table 91. KHB Details, Company Type, Molecular in Vitro Diagnostics Area Served and Its Competitors Table 92. KHB Molecular in Vitro Diagnostics Product Offered Table 93. KHB Main Business Table 94. KHB Molecular in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 95. KHB Latest Developments Table 96. Daan Gene Details, Company Type, Molecular in Vitro Diagnostics Area Served and Its Competitors Table 97. Daan Gene Molecular in Vitro Diagnostics Product Offered Table 98. Daan Gene Main Business Table 99. Daan Gene Molecular in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 100. Daan Gene Latest Developments Table 101. Leadman Details, Company Type, Molecular in Vitro Diagnostics Area Served and Its Competitors Table 102. Leadman Molecular in Vitro Diagnostics Product Offered Table 103. Leadman Molecular in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 104. Leadman Main Business Table 105. Leadman Latest Developments Table 106. Zhongsheng Details, Company Type, Molecular in Vitro Diagnostics Area Served and Its Competitors Table 107. Zhongsheng Molecular in Vitro Diagnostics Product Offered Table 108. Zhongsheng Main Business Table 109. Zhongsheng Molecular in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 110. Zhongsheng Latest Developments Table 111. Bsbe Details, Company Type, Molecular in Vitro Diagnostics Area Served and Its Competitors Table 112. Bsbe Molecular in Vitro Diagnostics Product Offered Table 113. Bsbe Main Business Table 114. Bsbe Molecular in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 115. Bsbe Latest Developments Table 116. Maccura Details, Company Type, Molecular in Vitro Diagnostics Area Served and Its Competitors Table 117. Maccura Molecular in Vitro Diagnostics Product Offered Table 118. Maccura Main Business Table 119. Maccura Molecular in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 120. Maccura Latest Developments Table 121. Hitachi Details, Company Type, Molecular in Vitro Diagnostics Area Served and Its Competitors Table 122. Hitachi Molecular in Vitro Diagnostics Product Offered Table 123. Hitachi Main Business Table 124. Hitachi Molecular in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 125. Hitachi Latest Developments Table 126. Canon Details, Company Type, Molecular in Vitro Diagnostics Area Served and Its Competitors Table 127. Canon Molecular in Vitro Diagnostics Product Offered Table 128. Canon Main Business Table 129. Canon Molecular in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 130. Canon Latest Developments Table 131. Sysmex Details, Company Type, Molecular in Vitro Diagnostics Area Served and Its Competitors Table 132. Sysmex Molecular in Vitro Diagnostics Product Offered Table 133. Sysmex Main Business Table 134. Sysmex Molecular in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 135. Sysmex Latest Developments Table 136. Auto Bio Details, Company Type, Molecular in Vitro Diagnostics Area Served and Its Competitors Table 137. Auto Bio Molecular in Vitro Diagnostics Product Offered Table 138. Auto Bio Main Business Table 139. Auto Bio Molecular in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 140. Auto Bio Latest Developments Table 141. Mindray Details, Company Type, Molecular in Vitro Diagnostics Area Served and Its Competitors Table 142. Mindray Molecular in Vitro Diagnostics Product Offered Table 143. Mindray Main Business Table 144. Mindray Molecular in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 145. Mindray Latest Developments Table 146. Bgi Details, Company Type, Molecular in Vitro Diagnostics Area Served and Its Competitors Table 147. Bgi Molecular in Vitro Diagnostics Product Offered Table 148. Bgi Main Business Table 149. Bgi Molecular in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 150. Bgi Latest Developments Table 151. Wondfo Details, Company Type, Molecular in Vitro Diagnostics Area Served and Its Competitors Table 152. Wondfo Molecular in Vitro Diagnostics Product Offered Table 153. Wondfo Molecular in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 154. Wondfo Main Business Table 155. Wondfo Latest Developments

Figure 1. Molecular in Vitro Diagnostics Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Molecular in Vitro Diagnostics Market Size Growth Rate 2019-2030 ($ Millions) Figure 6. Molecular in Vitro Diagnostics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions) Figure 7. Molecular in Vitro Diagnostics Sales Market Share by Country/Region (2023) Figure 8. Molecular in Vitro Diagnostics Sales Market Share by Country/Region (2019, 2023 & 2030) Figure 9. Global Molecular in Vitro Diagnostics Market Size Market Share by Type in 2023 Figure 10. Molecular in Vitro Diagnostics in Genetic Disease Figure 11. Global Molecular in Vitro Diagnostics Market: Genetic Disease (2019-2024) & ($ Millions) Figure 12. Molecular in Vitro Diagnostics in Infectious Diseases Figure 13. Global Molecular in Vitro Diagnostics Market: Infectious Diseases (2019-2024) & ($ Millions) Figure 14. Molecular in Vitro Diagnostics in Tumor Figure 15. Global Molecular in Vitro Diagnostics Market: Tumor (2019-2024) & ($ Millions) Figure 16. Molecular in Vitro Diagnostics in Other Figure 17. Global Molecular in Vitro Diagnostics Market: Other (2019-2024) & ($ Millions) Figure 18. Global Molecular in Vitro Diagnostics Market Size Market Share by Application in 2023 Figure 19. Global Molecular in Vitro Diagnostics Revenue Market Share by Player in 2023 Figure 20. Global Molecular in Vitro Diagnostics Market Size Market Share by Regions (2019-2024) Figure 21. Americas Molecular in Vitro Diagnostics Market Size 2019-2024 ($ Millions) Figure 22. APAC Molecular in Vitro Diagnostics Market Size 2019-2024 ($ Millions) Figure 23. Europe Molecular in Vitro Diagnostics Market Size 2019-2024 ($ Millions) Figure 24. Middle East & Africa Molecular in Vitro Diagnostics Market Size 2019-2024 ($ Millions) Figure 25. Americas Molecular in Vitro Diagnostics Value Market Share by Country in 2023 Figure 26. United States Molecular in Vitro Diagnostics Market Size Growth 2019-2024 ($ Millions) Figure 27. Canada Molecular in Vitro Diagnostics Market Size Growth 2019-2024 ($ Millions) Figure 28. Mexico Molecular in Vitro Diagnostics Market Size Growth 2019-2024 ($ Millions) Figure 29. Brazil Molecular in Vitro Diagnostics Market Size Growth 2019-2024 ($ Millions) Figure 30. APAC Molecular in Vitro Diagnostics Market Size Market Share by Region in 2023 Figure 31. APAC Molecular in Vitro Diagnostics Market Size Market Share by Type in 2023 Figure 32. APAC Molecular in Vitro Diagnostics Market Size Market Share by Application in 2023 Figure 33. China Molecular in Vitro Diagnostics Market Size Growth 2019-2024 ($ Millions) Figure 34. Japan Molecular in Vitro Diagnostics Market Size Growth 2019-2024 ($ Millions) Figure 35. Korea Molecular in Vitro Diagnostics Market Size Growth 2019-2024 ($ Millions) Figure 36. Southeast Asia Molecular in Vitro Diagnostics Market Size Growth 2019-2024 ($ Millions) Figure 37. India Molecular in Vitro Diagnostics Market Size Growth 2019-2024 ($ Millions) Figure 38. Australia Molecular in Vitro Diagnostics Market Size Growth 2019-2024 ($ Millions) Figure 39. Europe Molecular in Vitro Diagnostics Market Size Market Share by Country in 2023 Figure 40. Europe Molecular in Vitro Diagnostics Market Size Market Share by Type (2019-2024) Figure 41. Europe Molecular in Vitro Diagnostics Market Size Market Share by Application (2019-2024) Figure 42. Germany Molecular in Vitro Diagnostics Market Size Growth 2019-2024 ($ Millions) Figure 43. France Molecular in Vitro Diagnostics Market Size Growth 2019-2024 ($ Millions) Figure 44. UK Molecular in Vitro Diagnostics Market Size Growth 2019-2024 ($ Millions) Figure 45. Italy Molecular in Vitro Diagnostics Market Size Growth 2019-2024 ($ Millions) Figure 46. Russia Molecular in Vitro Diagnostics Market Size Growth 2019-2024 ($ Millions) Figure 47. Middle East & Africa Molecular in Vitro Diagnostics Market Size Market Share by Region (2019-2024) Figure 48. Middle East & Africa Molecular in Vitro Diagnostics Market Size Market Share by Type (2019-2024) Figure 49. Middle East & Africa Molecular in Vitro Diagnostics Market Size Market Share by Application (2019-2024) Figure 50. Egypt Molecular in Vitro Diagnostics Market Size Growth 2019-2024 ($ Millions) Figure 51. South Africa Molecular in Vitro Diagnostics Market Size Growth 2019-2024 ($ Millions) Figure 52. Israel Molecular in Vitro Diagnostics Market Size Growth 2019-2024 ($ Millions) Figure 53. Turkey Molecular in Vitro Diagnostics Market Size Growth 2019-2024 ($ Millions) Figure 54. GCC Country Molecular in Vitro Diagnostics Market Size Growth 2019-2024 ($ Millions) Figure 55. Americas Molecular in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 56. APAC Molecular in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 57. Europe Molecular in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 58. Middle East & Africa Molecular in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 59. United States Molecular in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 60. Canada Molecular in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 61. Mexico Molecular in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 62. Brazil Molecular in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 63. China Molecular in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 64. Japan Molecular in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 65. Korea Molecular in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 66. Southeast Asia Molecular in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 67. India Molecular in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 68. Australia Molecular in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 69. Germany Molecular in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 70. France Molecular in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 71. UK Molecular in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 72. Italy Molecular in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 73. Russia Molecular in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 74. Spain Molecular in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 75. Egypt Molecular in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 76. South Africa Molecular in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 77. Israel Molecular in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 78. Turkey Molecular in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 79. GCC Countries Molecular in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 80. Global Molecular in Vitro Diagnostics Market Size Market Share Forecast by Type (2025-2030) Figure 81. Global Molecular in Vitro Diagnostics Market Size Market Share Forecast by Application (2025-2030)

Related Reports

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. Read More

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. Read More

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. Read More

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). Read More

Buy Now

Safe and Secure SSL Encrypted

Quick Contacts

Want to customize this report?

We offer 10% Free Customization at the time of purchase

Get Free Customization

I'm Available

Anupriya Singh

Business Development Manager

Interested to schedule a FACE-TO-FACE meeting? Schedule a Call

Trusted Partners

Budget constraints? Get in touch with us for special pricing

Request Discount

Order Detail

Order Placed (25 January, 2025)
Notify To Team (25 January, 2025)
Report updation (26 January, 2025)
Report Quality Check (26 January, 2025)
Report Dispatch (27 January, 2025)

Email
Hard Copy

Research Methodology

An Adaptive Approach to Modern-day Research Needs

Get Methodology

Searching...

Global Molecular in Vitro Diagnostics Market Growth (Status and Outlook) 2024-2030

2024